메뉴 건너뛰기




Volumn 150, Issue 8, 2015, Pages 739-745

Erratum: Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ:APopulation-BasedCohort Study (JAMA Surgery) doi:10.1001/jamasurg.2015.0876;Survival benefit of breast surgery for low-grade ductal carcinoma in situ a population-based cohort study

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; BREAST NEOPLASMS; CANCER REGISTRY; CARCINOMA, INTRADUCTAL, NONINFILTRATING; LONGITUDINAL STUDY; MASTECTOMY; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; UNITED STATES;

EID: 84939810960     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.0876     Document Type: Erratum
Times cited : (159)

References (34)
  • 2
    • 76349088705 scopus 로고    scopus 로고
    • National Institutes of Health State-of-the-Science Conference statement: Diagnosis and management of ductal carcinoma in situ September 22-24, 2009
    • Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst. 2010;102(3):161-169.
    • (2010) J Natl Cancer Inst. , vol.102 , Issue.3 , pp. 161-169
    • Allegra, C.J.1    Aberle, D.R.2    Ganschow, P.3
  • 3
    • 0034990786 scopus 로고    scopus 로고
    • Histological and biological evolution of human premalignant breast disease
    • Allred DC, Mohsin SK, Fuqua SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer. 2001;8(1):47-61.
    • (2001) Endocr Relat Cancer. , vol.8 , Issue.1 , pp. 47-61
    • Allred, D.C.1    Mohsin, S.K.2    Fuqua, S.A.3
  • 4
    • 0030658933 scopus 로고    scopus 로고
    • Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find?
    • Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127 (11):1023-1028.
    • (1997) Ann Intern Med. , vol.127 , Issue.11 , pp. 1023-1028
    • Welch, H.G.1    Black, W.C.2
  • 5
    • 0029121769 scopus 로고
    • Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
    • Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197-1200.
    • (1995) Cancer. , vol.76 , Issue.7 , pp. 1197-1200
    • Page, D.L.1    Dupont, W.D.2    Rogers, L.W.3    Jensen, R.A.4    Schuyler, P.A.5
  • 6
    • 0020066273 scopus 로고
    • Intraductal carcinoma of the breast: Follow-up after biopsy only
    • Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49(4):751-758.
    • (1982) Cancer. , vol.49 , Issue.4 , pp. 751-758
    • Page, D.L.1    Dupont, W.D.2    Rogers, L.W.3    Landenberger, M.4
  • 8
    • 84880814807 scopus 로고    scopus 로고
    • Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery
    • Benson JR, Wishart GC. Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol. 2013;14(9):e348-e357.
    • (2013) Lancet Oncol. , vol.14 , Issue.9 , pp. e348-e357
    • Benson, J.R.1    Wishart, G.C.2
  • 9
    • 79952845819 scopus 로고    scopus 로고
    • Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
    • Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478-488.
    • (2011) J Natl Cancer Inst. , vol.103 , Issue.6 , pp. 478-488
    • Wapnir, I.L.1    Dignam, J.J.2    Fisher, B.3
  • 10
    • 79851509160 scopus 로고    scopus 로고
    • Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: A meta-analysis
    • Wang S-Y, Shamliyan T, Virnig BA, Kane R. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat. 2011; 127(1):1-14.
    • (2011) Breast Cancer Res Treat. , vol.127 , Issue.1 , pp. 1-14
    • Wang, S.-Y.1    Shamliyan, T.2    Virnig, B.A.3    Kane, R.4
  • 11
    • 76349106646 scopus 로고    scopus 로고
    • Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes
    • Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170-178.
    • (2010) J Natl Cancer Inst. , vol.102 , Issue.3 , pp. 170-178
    • Virnig, B.A.1    Tuttle, T.M.2    Shamliyan, T.3    Kane, R.L.4
  • 12
    • 77951643029 scopus 로고    scopus 로고
    • NIH state-of-the-science conference statement: Diagnosis and management of ductal carcinoma in situ (DCIS)
    • Allegra CJ, Aberle DR, Ganschow P, et al. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). NIH Consens State Sci Statements. 2009;26(2):1-27.
    • (2009) NIH Consens State Sci Statements. , vol.26 , Issue.2 , pp. 1-27
    • Allegra, C.J.1    Aberle, D.R.2    Ganschow, P.3
  • 14
    • 33846873244 scopus 로고    scopus 로고
    • Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models
    • Horton NJ, Kleinman KP. Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models. Am Stat. 2007;61(1):79-90.
    • (2007) Am Stat. , vol.61 , Issue.1 , pp. 79-90
    • Horton, N.J.1    Kleinman, K.P.2
  • 15
    • 84856270792 scopus 로고    scopus 로고
    • Multiple imputation by chained equations (MICE): Implementation in Stata
    • Royston P, White IR. Multiple imputation by chained equations (MICE): implementation in Stata. J Stat Softw. 2011;45:1-20.
    • (2011) J Stat Softw. , vol.45 , pp. 1-20
    • Royston, P.1    White, I.R.2
  • 16
    • 0033616909 scopus 로고    scopus 로고
    • Multiple imputation of missing blood pressure covariates in survival analysis
    • van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6): 681-694.
    • (1999) Stat Med. , vol.18 , Issue.6 , pp. 681-694
    • Van Buuren, S.1    Boshuizen, H.C.2    Knook, D.L.3
  • 17
    • 0000157861 scopus 로고
    • Model-based direct adjustment
    • Rosenbaum PR. Model-based direct adjustment. J Am Stat Assoc. 1987;82:387-394.
    • (1987) J Am Stat Assoc. , vol.82 , pp. 387-394
    • Rosenbaum, P.R.1
  • 18
    • 79958704133 scopus 로고    scopus 로고
    • An introduction to propensity score methods for reducing the effects of confounding in observational studies
    • Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011; 46(3):399-424.
    • (2011) Multivariate Behav Res. , vol.46 , Issue.3 , pp. 399-424
    • Austin, P.C.1
  • 20
    • 84949193513 scopus 로고
    • Reducing bias in observational studies using subclassification on the propensity score
    • Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
    • (1984) J Am Stat Assoc. , vol.79 , pp. 516-524
    • Rosenbaum, P.R.1    Rubin, D.B.2
  • 21
    • 70350710119 scopus 로고    scopus 로고
    • Rethinking screening for breast cancer and prostate cancer
    • Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685-1692.
    • (2009) JAMA. , vol.302 , Issue.15 , pp. 1685-1692
    • Esserman, L.1    Shieh, Y.2    Thompson, I.3
  • 22
    • 84899752622 scopus 로고    scopus 로고
    • Addressing overdiagnosis and overtreatment in cancer: A prescription for change
    • Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014;15(6):e234-e242.
    • (2014) Lancet Oncol. , vol.15 , Issue.6 , pp. e234-e242
    • Esserman, L.J.1    Thompson, I.M.2    Reid, B.3
  • 24
    • 84869451873 scopus 로고    scopus 로고
    • Effect of three decades of screening mammography on breast-cancer incidence
    • Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
    • (2012) N Engl J Med. , vol.367 , Issue.21 , pp. 1998-2005
    • Bleyer, A.1    Welch, H.G.2
  • 25
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • Wilt TJ, Brawer MK, Jones KM, et al; Prostate Cancer Intervention vs Observation Trial (PIVOT) Study Group. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203-213.
    • (2012) N Engl J Med. , vol.367 , Issue.3 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 26
    • 77952054026 scopus 로고    scopus 로고
    • Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis
    • Kerlikowske K, Molinaro AM, Gauthier ML, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010;102(9):627-637.
    • (2010) J Natl Cancer Inst. , vol.102 , Issue.9 , pp. 627-637
    • Kerlikowske, K.1    Molinaro, A.M.2    Gauthier, M.L.3
  • 27
    • 84877010781 scopus 로고    scopus 로고
    • Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
    • Lazzeroni M, Guerrieri-Gonzaga A, Botteri E, et al. Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype. Br J Cancer. 2013;108(8): 1593-1601.
    • (2013) Br J Cancer. , vol.108 , Issue.8 , pp. 1593-1601
    • Lazzeroni, M.1    Guerrieri-Gonzaga, A.2    Botteri, E.3
  • 28
    • 84880142464 scopus 로고    scopus 로고
    • Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively
    • Vandenbussche CJ, Khouri N, Sbaity E, et al. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol. 2013;37(6):913-923.
    • (2013) Am J Surg Pathol. , vol.37 , Issue.6 , pp. 913-923
    • Vandenbussche, C.J.1    Khouri, N.2    Sbaity, E.3
  • 29
    • 84891771750 scopus 로고    scopus 로고
    • Ductal carcinoma in situ of the breast: Can biomarkers improve current management?
    • Bartlett JMS, Nofech-Moses S, Rakovitch E. Ductal carcinoma in situ of the breast: can biomarkers improve current management? Clin Chem. 2014;60(1):60-67.
    • (2014) Clin Chem. , vol.60 , Issue.1 , pp. 60-67
    • Jms, B.1    Nofech-Moses, S.2    Rakovitch, E.3
  • 30
    • 84890427442 scopus 로고    scopus 로고
    • Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
    • Siziopikou KP, Anderson SJ, Cobleigh MA, et al. Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Res Treat. 2013;142(2):415-421.
    • (2013) Breast Cancer Res Treat. , vol.142 , Issue.2 , pp. 415-421
    • Siziopikou, K.P.1    Anderson, S.J.2    Cobleigh, M.A.3
  • 31
    • 68249114452 scopus 로고    scopus 로고
    • Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls
    • Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
    • (2009) BMJ. , vol.338 , pp. b2393
    • Jac, S.1    White, I.R.2    Carlin, J.B.3
  • 32
    • 84864924629 scopus 로고    scopus 로고
    • Use of imputed population-based cancer registry data as a method of accounting for missing information: Application to estrogen receptor status for breast cancer
    • Howlader N, Noone AM, Yu M, Cronin KA. Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol. 2012;176(4):347-356.
    • (2012) Am J Epidemiol. , vol.176 , Issue.4 , pp. 347-356
    • Howlader, N.1    Noone, A.M.2    Yu, M.3    Cronin, K.A.4
  • 34
    • 84983439853 scopus 로고    scopus 로고
    • Comparison of SEER treatment data with Medicare claims [published online March 15, 2014]
    • Noone AM, Lund JL, Mariotto A, et al. Comparison of SEER treatment data with Medicare claims [published online March 15, 2014]. Med Care. 2014.
    • (2014) Med Care.
    • Noone, A.M.1    Lund, J.L.2    Mariotto, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.